Actively Recruiting
Clinical Performance of Urine HPV Testing in Males
Led by Peking University People's Hospital · Updated on 2024-11-05
150
Participants Needed
2
Research Sites
25 weeks
Total Duration
On this page
Sponsors
P
Peking University People's Hospital
Lead Sponsor
H
Hangzhou Newhorizon Health Technology Co., Ltd.
Collaborating Sponsor
AI-Summary
What this Trial Is About
Human papillomavirus (HPV) infection is one of the most prevalent viral infections of the genital tract, primarily transmitted through sexual contact. Research indicates that individuals engaging in sexual activity have a lifetime probability of HPV infection as high as 85% to 90%. While extensive and in-depth investigations have been conducted on HPV infection in women, epidemiological studies focusing on male HPV infection remain relatively scarce. Many men with HPV are asymptomatic; reports suggest that approximately 10.5% of men in China are infected with HPV, yet only about 1% exhibit related symptoms. This substantial population of asymptomatic and unaware patients poses significant challenges for the prevention and control efforts regarding HPV in China. Furthermore, evidence suggests an association between HPV infection and conditions such as condyloma acuminatum, penile intraepithelial neoplasia (PeIN), penile cancer (PA), and even infertility among male patients. In current clinical practice, detection of HPV typically involves collecting exfoliated cells from the external genitalia via swabs. The discomfort associated with this sampling method and its procedural complexity often deter many asymptomatic men from undergoing penile swab testing for HPV, resulting in low compliance rates. Self-sampling urine tests offer advantages including convenience, ease of use, painlessness, and non-invasiveness; thus they may serve as a viable alternative approach. In prior research endeavors, we successfully established a detection system utilizing female urine samples for identifying HPV presence. Consequently, this study aims to further refine this detection system to develop a stable and reliable methodology for detecting HPV using self-collected urine samples from males. Through this investigation not only do we seek to validate the feasibility of employing self-collected urine samples for detecting male HPV infections but also assess the accuracy and practicality of home-based self-testing methods among subjects-ultimately providing novel strategies for male-specific HPV detection
CONDITIONS
Official Title
Clinical Performance of Urine HPV Testing in Males
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be at least 18 years old and have had sexual experience
- Have had one year or more of regular, unprotected sexual activity without pregnancy in married couples
- Voluntarily participate in this study after communication and sign an informed consent form
You will not qualify if you...
- Samples that cannot provide valid nucleic acid test results due to errors or insufficient volume
- Incomplete demographic or laboratory test information from the subjects
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Peking University People's Hospital
Beijing, Beijing Municipality, China, 100000
Not Yet Recruiting
2
Peking University People's Hospital
Beijing, Beijing Municipality, China, 100000
Actively Recruiting
Research Team
Y
Yongping Zhao, Chief physician
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here